Joanna Wiensch
Stock Analyst at Citigroup
(2.55)
# 2,232
Out of 5,114 analysts
30
Total ratings
71.43%
Success rate
8.23%
Average return
Main Sectors:
Stocks Rated by Joanna Wiensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Downgrades: Neutral | $217 → $185 | $201.92 | -8.38% | 7 | May 22, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $119 → $127 | $106.05 | +19.75% | 8 | Aug 22, 2024 | |
| DXCM DexCom | Maintains: Buy | $83 → $90 | $73.36 | +23.02% | 2 | Apr 29, 2020 | |
| COO The Cooper Companies | Maintains: Neutral | $90 → $80 | $80.48 | -1.22% | 2 | Mar 27, 2020 | |
| IRTC iRhythm Holdings | Initiates: Buy | $120 | $151.85 | -20.97% | 1 | Mar 5, 2020 | |
| PEN Penumbra | Initiates: Buy | $200 | $359.03 | -44.29% | 1 | Mar 5, 2020 | |
| GKOS Glaukos | Initiates: Sell | $40 | $123.94 | -67.73% | 1 | Mar 5, 2020 | |
| ZBH Zimmer Biomet Holdings | Initiates: Buy | $168 | $85.71 | +96.01% | 1 | Mar 5, 2020 | |
| ALC Alcon | Initiates: Neutral | $63 | $80.42 | -21.66% | 1 | Mar 5, 2020 | |
| SYK Stryker | Initiates: Buy | $235 | $357.83 | -34.33% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $220 | $258.20 | -14.79% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $84 | $81.86 | +2.61% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $94 | $19.61 | +379.35% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $163 | $227.72 | -28.42% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $124 | $100.79 | +23.03% | 1 | Mar 5, 2020 |
Becton, Dickinson and Company
May 22, 2025
Downgrades: Neutral
Price Target: $217 → $185
Current: $201.92
Upside: -8.38%
Abbott Laboratories
Aug 22, 2024
Maintains: Buy
Price Target: $119 → $127
Current: $106.05
Upside: +19.75%
DexCom
Apr 29, 2020
Maintains: Buy
Price Target: $83 → $90
Current: $73.36
Upside: +23.02%
The Cooper Companies
Mar 27, 2020
Maintains: Neutral
Price Target: $90 → $80
Current: $80.48
Upside: -1.22%
iRhythm Holdings
Mar 5, 2020
Initiates: Buy
Price Target: $120
Current: $151.85
Upside: -20.97%
Penumbra
Mar 5, 2020
Initiates: Buy
Price Target: $200
Current: $359.03
Upside: -44.29%
Glaukos
Mar 5, 2020
Initiates: Sell
Price Target: $40
Current: $123.94
Upside: -67.73%
Zimmer Biomet Holdings
Mar 5, 2020
Initiates: Buy
Price Target: $168
Current: $85.71
Upside: +96.01%
Alcon
Mar 5, 2020
Initiates: Neutral
Price Target: $63
Current: $80.42
Upside: -21.66%
Stryker
Mar 5, 2020
Initiates: Buy
Price Target: $235
Current: $357.83
Upside: -34.33%
Mar 5, 2020
Initiates: Buy
Price Target: $220
Current: $258.20
Upside: -14.79%
Mar 5, 2020
Initiates: Buy
Price Target: $84
Current: $81.86
Upside: +2.61%
Mar 5, 2020
Initiates: Neutral
Price Target: $94
Current: $19.61
Upside: +379.35%
Mar 5, 2020
Initiates: Buy
Price Target: $163
Current: $227.72
Upside: -28.42%
Mar 5, 2020
Initiates: Buy
Price Target: $124
Current: $100.79
Upside: +23.03%